SEC Company Response from Autolus Therapeutics plc (AUTL) (CIK 0001730463) (AUTL) — Jul 22, 2019
Autolus Therapeutics plc (AUTL) (CIK 0001730463)
Date: July 22, 2019 · CIK: 0001730463 · Accession: 0001193125-19-198985
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-232690
Letter
Forest House
58 Wood Lane
White City
London W12 7RZ
United Kingdom
VIA EDGAR
July 22, 2019
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Autolus Therapeutics plc
Registration Statement on Form F-3
File No. 333-232690
Acceleration Request
Requested Date:
July 24, 2019
Requested Time:
4:00 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form F-3 (the “Registration Statement”) to become effective on July 24, 2019, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable, or at such later time as its counsel may orally request via telephone call to the staff. The Registrant hereby authorizes each of Darren DeStefano, Courtney Thorne and William DuVal of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Darren DeStefano of Cooley LLP at (703) 456-8034, or in his absence, Courtney Thorne at (617) 937-2318. Thank you for your assistance with this matter.
Sincerely,
AUTOLUS THERAPEUTICS PLC
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
Forest House
58 Wood Lane
White City
London W12 7RZ
United Kingdom
VIA EDGAR
July 22, 2019
U.S.
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Autolus Therapeutics plc
Registration Statement on Form F-3
File No. 333-232690
Acceleration Request
Requested Date:
July 24, 2019
Requested Time:
4:00 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the
“Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form F-3 (the
“Registration Statement”) to become effective on July 24, 2019, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable, or at such later time as its counsel may orally request via telephone call to the
staff. The Registrant hereby authorizes each of Darren DeStefano, Courtney Thorne and William DuVal of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Darren DeStefano of Cooley LLP at (703) 456-8034, or in his absence, Courtney Thorne at (617) 937-2318. Thank you for your assistance with this matter.
Sincerely,
AUTOLUS THERAPEUTICS PLC
By:
/s/ Christian Itin
Christian Itin
Chief Executive Officer
cc:
Matthias Alder, Autolus Therapeutics plc
Alex Driggs, Autolus Therapeutics plc
Darren DeStefano, Cooley LLP
Christian Plaza, Cooley LLP
Courtney Thorne, Cooley LLP